PCN70 The Cost Effectiveness of Degarelix for the Treatment of Prostate Cancer in the UK
Nov 1, 2012, 00:00 AM
10.1016/j.jval.2012.08.2110
https://www.valueinhealthjournal.com/article/S1098-3015(12)03824-7/fulltext
Section Title :
Cancer
Section Order :
760
First Page :
A421
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)03824-7&doi=10.1016/j.jval.2012.08.2110